TABLE 5.
Association of PRBCT with OS within the PS strata
| Propensity Score Strata (Range; Sample Size*) |
HR (95% CI) | P |
|---|---|---|
| Strata 1 (0.084–0.349; 45 and 21) | 1.08 (0.43–2.71) | 0.87 |
| Strata 2 (0.350–0.552; 40 and 27) | 1.27 (0.60–2.70) | 0.54 |
| Strata 3 (0.553–0.780; 25 and 41) | 0.82 (0.40–1.66) | 0.57 |
| Strata 4 (0.781–0.903; 10 and 57) | 0.95 (0.43–2.09) | 0.91 |
| Strata 5 (0.904–0.964; 4 and 63) | 0.41 (0.14–1.18) | 0.10 |
| Combined | 0.90 (0.62–1.30)† | 0.58 |
Number of non-PRBCT and PRBCT patients, respectively.
The estimates were combined across the 5 strata using an inverse-variance weighted mean.